
Adolescent and Young Adult Neuro-Oncology Clinic
The UCSF Adolescent and Young Adult (AYA) Neuro-Oncology Clinic cares for patients ages 18 to 39 affected by brain tumors, including those who previously received treatment through the Pediatric Brain Tumor Program. We specialize in treating patients with brain tumors that occur outside of the typical age ranges, such as adults with brain tumors that traditionally occur in children.
Our clinic is one of the few clinics dedicated to AYA neuro-oncology in the world. Our specialists have expertise in the latest treatments and technologies for both adult and pediatric brain tumors, and our mission is to bring our patients the best possible outcomes and quality of life. What's more, our clinic facilitates access to clinical trials (studies that evaluate promising new therapies).
As part of the UCSF Brain Tumor Center, we also provide patients and their families with resources and support, including a caregiver program, neurocognitive care services and a survivorship program.
Our locations (1)
Our team
Awards & recognition
-
Best in Northern California and No. 7 in the nation for cancer care
-
Best in the West and No. 3 in the nation for neurology & neurosurgery
-
in the U.S. for number of brain tumor patients treated
Support services
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your condition
- List of your medications, including dosages, plus any you're allergic to
- List of questions you may have
- Device or paper for taking notes
Our research initiatives
-
UCSF Brain Tumor Center Clinical Trials
The UCSF Brain Tumor Center is home to many laboratories dedicated to improving the understanding and treatment of brain cancer. The labs explore aspects of brain tumor risk, biology, diagnosis and treatment.
-
UCSF Helen Diller Family Comprehensive Cancer Center Research
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.